Latest Breaking News On - Mark rothera - Page 1 : comparemela.com

Viracta Therapeutics Appoints Michael Faerm as Chief Financial Officer

Viracta Therapeutics Appoints Michael Faerm as Chief Financial Officer
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Ashleigh barretoMichael faermMark rotheraTheravance incViracta therapeutics incStanford universityRegeneron pharmaceuticalsHarvard business schoolHarpoon therapeutics incArtiva biotherapeutics incMerrill lynchHead of investor relations corporate communicationsColumbia universityCredit suisseInnoviva incTherapeutics appoints michael faerm

Viracta Therapeutics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference

Viracta Therapeutics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Darrelp cohenMark rotheraAshleigh barretoViracta therapeutics incHealthcare life sciences conference onHealthcare life sciences conferenceHead of investor relations corporate communicationsAnnual healthcare life sciencesChief executive officerChief medical officerAnnual healthcare life sciences conferenceViracta therapeuticsRelations contactInvestor relations

INVO, NAYA announce new board members ahead of merger (NASDAQ:INVO)

INVO, NAYA announce new board members ahead of merger (NASDAQ:INVO)
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

Mark rotheraPrakash ramanMaksim labkouskiLaurent audolyPatrick tricoliLyn falconioNovartis institute of biomedical researchApollo health venturesKymera therapeuticsRibon therapeuticsNovartis instituteBiomedical researchViracta therapeuticsSilence therapeutics

INVO Bioscience Files S-4 Registration and Preliminary Joint Proxy Statements in Connection with Merger with NAYA Biosciences, NAYA Announces New Board Directors

INVO Bioscience Files S-4 Registration and Preliminary Joint Proxy Statements in Connection with Merger with NAYA Biosciences, NAYA Announces New Board Directors
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesLaurent audolyPrakash ramanRobert blumLyn falconioSteve shumDaniel teperMark rotheraPearl cohenPatrick tricoliGlaser weilPeter kashGilles seydouxHead of global business development at nanobiotixBusiness developmentExchange commission

Viracta Therapeutics (VIRX) Provides Clinical Update and Outlook for 2024

Viracta Therapeutics (VIRX) Provides Clinical Update and Outlook for 2024
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Mark rotheraDrug administrationViracta therapeutics incSasia congressViracta therapeuticsChief executive officer